Investigation of Pharmaceutical Product Development by Securities Lawyers at Goldfarb Branham Law Firm LLP for Potential Shareh

^{Published on 2011-10-04 17:20:47 - Market Wire}
 

Investigation of Pharmaceutical Product Development by Securities Lawyers at Goldfarb Branham Law Firm... -- DALLAS, Oct. 4, 2011 /PRNewswire/ --

[ ]

My news for Investors

AtLeast one of the check box should be selected You are following news about Follow the latest news about PPDI

DALLAS, Oct. 4, 2011 /PRNewswire/ -- [ Goldfarb Branham LLP ] is investigating whether the board of directors of Pharmaceutical Product Development (NASDAQ: [ PPDI ]) violated shareholder protection laws by agreeing to sell the company for $33.25 per share. Concerned investors are encouraged to contact attorney Hamilton Lindley at 877-583-2855 or [ hlindley@goldfarbbranham.com ] about their rights and remedies.

"As recently as mid-August, shares of the company were trading at $32.20 per share," securities lawyer Hamilton Lindley said.  "Additionally, at least one analyst set a target price of $38.00 per share on the PPDI stock.  Our proposed shareholder class action lawsuit seeks to ensure that investors get the most value for their stock in this buyout."

[ Goldfarb Branham LLP ] lawyers have significant experience representing shareholders and whistleblowers in securities lawsuits nationwide. Pharmaceutical Product Development stockholders – or anyone with knowledge about this acquisition – should contact lawyer Hamilton Lindley at [ hlindley@goldfarbbranham.com ] or 877-583-2855.

Hamilton Lindley
Goldfarb Branham LLP
2501 N. Harwood, Ste. 1801
Dallas, TX 75201
(877) 583-2855 Toll Free Telephone
(214) 583-2233 Local Phone Number
(214) 583-2234 Fax Number
[ hlindley@goldfarbbranham.com ]
[ www.goldfarbbranham.com ]

SOURCE Goldfarb Branham LLP

RELATED LINKS
[ http://www.goldfarbbranham.com ]